Skip to main content

beta This is a new site, your feedback will help us to improve it.

Retroperitoneal lymph node dissection

Published on 22 April 2021

The service provides treatment for people with metastatic germ cell cancer and it's based at the Queen Elizabeth University Hospital in Glasgow.

Retroperitoneal lymph node dissection (RPLND) is a specialist surgical procedure, which involves the removal of residual lymph nodes at the back of the abdomen.

When can patients benefit from the treatment?

RPLND aims to remove metastatic spread – when cancer cells move to other areas of the body. The vast majority of patients are men with testicular cancer. However, this surgery is occasionally in use to treat other diagnoses as well.

The Scottish caseload is approximately 20 cases per year and there is no age restriction. In most cases, adults require the treatment rather than children.

Lead clinician

Dr David Hendry

Address

Queen Elizabeth University Hospital
1345 Govan Road
Glasgow
G51 4TF

NSD contact

Programme Manager, Joanne Milne-Toner – joanne.milne-toner@nhs.scot – 0131 275 6558

Please note that NSD does not directly provide medical services and we won't be able to answer queries about your own care or appointments. If you would like to discuss any aspects of your care, please contact your primary healthcare provider. This might be your GP, Consultant, Nurse or other healthcare professional. They will be best placed to give you the right advice.